Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Trospium chloride 20 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 2.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 3 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Propiverine hydrochloride 15 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Atropine sulfate 10 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Atropine sulfate 10 mg/g eye ointment |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 5 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 10 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 20 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
papaveretum + skopolaminhydrobromid |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Atropine sulfate 1.25 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Atropine sulfate 5 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Atropine sulfate 20 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 150 microgram oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Hyoscine methylbromide 2.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 400 microgram oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Propantheline bromide 7.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Mepenzolate bromide 25 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely dicycloverine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 400 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely benzatropine mesilate 500 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Orphenadrine citrate 100 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Hyoscyamine sulfate 375 microgram oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Benzatropine mesilate 1 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Homatropine methylbromide 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Homatropine methylbromide 10 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Dicycloverine hydrochloride 20 mg oral capsule |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat + edrofoniumklorid |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely solifenacin succinate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Solifenacin succinate 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely trospium chloride 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
otiloniumbromid |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Fesoterodine fumarate 8 mg prolonged-release oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Ipratropium bromide 21 microgram/actuation nasal spray |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 1 mg/mL oral solution |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Procyclidine hydrochloride 500 microgram/mL oral solution |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely procyclidine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat 1,25 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/10 ml, injektionsvätska, lösning, spruta |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
skopolaminbutylbromid 20 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat 1 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat 3 mg/10 ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
atropinsulfat 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
procyklidinhydroklorid 10 mg/2 ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Aclidinium bromide 375 microgram/actuation powder for inhalation |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Ipratropium bromide 20 microgram/actuation pressurized solution for inhalation |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
Ipratropium bromide 40 microgram/actuation pressurized solution for inhalation |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|